Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Plug Power Inc (PLUG) vs ResMed Inc. (RMD) Price & Performance

Plug Power IncTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Plug Power Inc vs ResMed Inc. — how do they compare? Plug Power Inc trades at $2.23 (market cap $2.98B), while ResMed Inc. trades at $192.97 (market cap $28.40B). The key difference: ResMed Inc. is far larger — about 9.5× Plug Power Inc's market cap, and ResMed Inc. pays a 1.23% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.

PLUGRMD
Market Cap
$2.98B$28.40B
Sector
IndustrialsHealth
52-Week High
$4.14$293.73
52-Week Low
$1.40$182.82
Enterprise Value
$3.77B$27.58B
Dividend Yield
1.23%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Plug Power Inc

Plug Power (PLUG) trades at $2.27, up 5.58% on the day, but remains in a bearish technical trend with oversold RSI readings. The company shows persistent unprofitability with a -227.13% net margin and negative cash flows, though recent earnings have beaten estimates in two of the last three quarters. Positive developments include a 50-megawatt electrolyzer order in Australia and strategic asset sales aimed at boosting liquidity by over $275 million, providing some operational momentum amid financial challenges.

The outlook remains high-risk due to deep losses and cash burn, but analyst consensus is cautiously optimistic with a $2.92 price target (28% upside). Investment opportunity hinges on successful turnaround execution and hydrogen demand growth, while key risks include continued dilution, competitive pressure, and reliance on financing to fund operations. The stock's depressed valuation reflects significant skepticism, leaving room for volatility on news flow.

ResMed Inc.

ResMed (RMD) trades at $195.8, down 1.6% on the day, with a bearish technical signal but strong fundamentals. Recent quarterly earnings have consistently beaten estimates, with Q1 2026 EPS of $2.86 exceeding the $2.80 forecast. The company sold its MatrixCare business for $490 million in July 2026 to sharpen focus on connected care, signaling strategic refinement. Revenue growth remains robust, climbing to $5.15 billion in 2025, with net income margins expanding to 27.44%.

The outlook is supported by solid earnings momentum and a consensus price target of $245.88, implying 25.6% upside. Risks include competitive pressures in medical equipment and reliance on sleep apnea market growth. Analyst sentiment is mixed with 40% buy ratings, but institutional selling by Baader Bank in Q1 2026 warrants monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Plug Power Inc

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.

Read more on PLUG

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD